{
    "Trade/Device Name(s)": [
        "Innovacon FlipcardTM Fecal Occult Blood Test Device"
    ],
    "Submitter Information": "Innovacon, Inc.",
    "510(k) Number": "K063673",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHE"
    ],
    "Summary Letter Date": "March 5, 2007",
    "Summary Letter Received Date": "December 11, 2006",
    "Submission Date": "December 6, 2006",
    "Regulation Number(s)": [
        "21 CFR 864.6550"
    ],
    "Regulation Name(s)": [
        "Occult Blood Test"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Human hemoglobin",
        "Fecal occult blood"
    ],
    "Specimen Type(s)": [
        "Fecal"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Membrane particle assay",
        "Antigen/antibody immunoassay",
        "Double antibody sandwich assay",
        "Lateral-flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test Device",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Innovacon FlipcardTM rapid immunoassay for qualitative detection of fecal occult blood using monoclonal antibodies",
    "Indications for Use Summary": "Intended for rapid qualitative detection of human hemoglobin in fecal samples, aiding in screening for lower GI bleeding related to iron deficiency anemia, peptic ulcer, ulcerative colitis, polyp, and colorectal cancer; recommended for health professionals in routine exams and monitoring in hospitals or physician offices",
    "fda_folder": "Hematology"
}